A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children

Abstract Background IgA vasculitis (IgAV) is a small vessel vasculitis that is more common in childhood. Very limited evidence exists on patients who experience an atypical disease course. The aim of this study was to describe a cohort of children diagnosed with recurrent or persisting IgAV to ident...

Full description

Bibliographic Details
Main Authors: Julien Marro, Chloe Williams, Clare E. Pain, Louise Oni
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Online Access:https://doi.org/10.1186/s12969-023-00872-1
_version_ 1797577519419883520
author Julien Marro
Chloe Williams
Clare E. Pain
Louise Oni
author_facet Julien Marro
Chloe Williams
Clare E. Pain
Louise Oni
author_sort Julien Marro
collection DOAJ
description Abstract Background IgA vasculitis (IgAV) is a small vessel vasculitis that is more common in childhood. Very limited evidence exists on patients who experience an atypical disease course. The aim of this study was to describe a cohort of children diagnosed with recurrent or persisting IgAV to identify any themes associated with their disease course and areas of unmet needs. Methods A single centre retrospective study of children diagnosed with recurrent or persisting IgAV at Alder Hey Children’s Hospital (Liverpool, UK). Clinical data, including features at presentation and during follow up, potential triggers, abnormal laboratory and histology results, treatment and outcome at last clinical review were retrospectively collected. Key themes were identified. Results A total of 13 children met the inclusion criteria (recurrent disease, n = 4; persisting disease, n = 9). Median age at first presentation was 10.2 years [2.6–15.5], female:male ratio 1.2:1. Children in the atypical cohort were significantly older than a larger cohort of children who followed a non-complicated disease course (median age 5.5 years (range [0.6–16.7], p = 0.003)). All children re-presented with a purpuric rash (either recurring or persisting), accompanied by joint involvement in 92% of patients (12/13). Disease-modifying anti-rheumatic drugs (DMARDs) were used in 8/13 (62%) children. The median time from first presentation to diagnosis of atypical disease was 18.4 months [5.3-150.8] and the time from first presentation to treatment was 24.1 months [1.8–95.4]. Use of corticosteroids was significantly higher in children with renal involvement (p = 0.026). During follow up, 8/13 (62%) children were admitted at least once, whilst 10/13 (77%) had re-presented at least once to the emergency department. Five (38%) children were referred to psychology services and 7 (54%) children reported feelings of frustration. Conclusions This series describes some characteristics of a small cohort of children with atypical IgAV. It also identifies unmet needs in children with atypical IgAV, which includes delays in diagnosis and lengthy waits for treatment, lack of high-quality evidence regarding treatment choices and a high unrecognised disease burden. Further research is needed to study this subgroup of children as evidence is lacking.
first_indexed 2024-03-10T22:09:28Z
format Article
id doaj.art-88bf52e55cd14212848b5d5210f9c590
institution Directory Open Access Journal
issn 1546-0096
language English
last_indexed 2024-03-10T22:09:28Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Pediatric Rheumatology Online Journal
spelling doaj.art-88bf52e55cd14212848b5d5210f9c5902023-11-19T12:40:07ZengBMCPediatric Rheumatology Online Journal1546-00962023-08-012111910.1186/s12969-023-00872-1A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in childrenJulien Marro0Chloe Williams1Clare E. Pain2Louise Oni3Department of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of LiverpoolRoyal Liverpool and Broadgreeen University Hospital TrustsDepartment of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of LiverpoolDepartment of Women’s and Children’s Health, Institute of Life Course and Medical Sciences, University of LiverpoolAbstract Background IgA vasculitis (IgAV) is a small vessel vasculitis that is more common in childhood. Very limited evidence exists on patients who experience an atypical disease course. The aim of this study was to describe a cohort of children diagnosed with recurrent or persisting IgAV to identify any themes associated with their disease course and areas of unmet needs. Methods A single centre retrospective study of children diagnosed with recurrent or persisting IgAV at Alder Hey Children’s Hospital (Liverpool, UK). Clinical data, including features at presentation and during follow up, potential triggers, abnormal laboratory and histology results, treatment and outcome at last clinical review were retrospectively collected. Key themes were identified. Results A total of 13 children met the inclusion criteria (recurrent disease, n = 4; persisting disease, n = 9). Median age at first presentation was 10.2 years [2.6–15.5], female:male ratio 1.2:1. Children in the atypical cohort were significantly older than a larger cohort of children who followed a non-complicated disease course (median age 5.5 years (range [0.6–16.7], p = 0.003)). All children re-presented with a purpuric rash (either recurring or persisting), accompanied by joint involvement in 92% of patients (12/13). Disease-modifying anti-rheumatic drugs (DMARDs) were used in 8/13 (62%) children. The median time from first presentation to diagnosis of atypical disease was 18.4 months [5.3-150.8] and the time from first presentation to treatment was 24.1 months [1.8–95.4]. Use of corticosteroids was significantly higher in children with renal involvement (p = 0.026). During follow up, 8/13 (62%) children were admitted at least once, whilst 10/13 (77%) had re-presented at least once to the emergency department. Five (38%) children were referred to psychology services and 7 (54%) children reported feelings of frustration. Conclusions This series describes some characteristics of a small cohort of children with atypical IgAV. It also identifies unmet needs in children with atypical IgAV, which includes delays in diagnosis and lengthy waits for treatment, lack of high-quality evidence regarding treatment choices and a high unrecognised disease burden. Further research is needed to study this subgroup of children as evidence is lacking.https://doi.org/10.1186/s12969-023-00872-1Henoch schonlein purpuraIgAVChildrenChronicRecurrentPersisting
spellingShingle Julien Marro
Chloe Williams
Clare E. Pain
Louise Oni
A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
Pediatric Rheumatology Online Journal
Henoch schonlein purpura
IgAV
Children
Chronic
Recurrent
Persisting
title A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
title_full A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
title_fullStr A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
title_full_unstemmed A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
title_short A case series on recurrent and persisting IgA vasculitis (Henoch Schonlein purpura) in children
title_sort case series on recurrent and persisting iga vasculitis henoch schonlein purpura in children
topic Henoch schonlein purpura
IgAV
Children
Chronic
Recurrent
Persisting
url https://doi.org/10.1186/s12969-023-00872-1
work_keys_str_mv AT julienmarro acaseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT chloewilliams acaseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT clareepain acaseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT louiseoni acaseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT julienmarro caseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT chloewilliams caseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT clareepain caseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren
AT louiseoni caseseriesonrecurrentandpersistingigavasculitishenochschonleinpurpurainchildren